SYNENDOS THERAPEUTICS
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.
SYNENDOS THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2019-04-01
Address:
Allschwil, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.synendos.com
Total Employee:
1+
Status:
Active
Total Funding:
44.26 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Lorem Ipsum
Current Advisors List
Current Employees Featured
Founder
Investors List
Ysios Capital
Ysios Capital investment in Series A - Synendos Therapeutics
Lichtsteiner Foundation
Lichtsteiner Foundation investment in Series A - Synendos Therapeutics
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - Synendos Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Synendos Therapeutics
Kurma Partners
Kurma Partners investment in Series A - Synendos Therapeutics
Essential Investment Partners
Essential Investment Partners investment in Series A - Synendos Therapeutics
Bernina BioInvest
Bernina BioInvest investment in Series A - Synendos Therapeutics
Schroder Adveq
Schroder Adveq investment in Series A - Synendos Therapeutics
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Synendos Therapeutics
Venture Kick
Venture Kick investment in Pre Seed Round - Synendos Therapeutics
Newest Events participated
Official Site Inspections
http://www.synendos.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.92 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
